Journal • Tumor mutational burden • PD(L)-1 Biomarker • IO biomarker
|
KRAS (KRAS proto-oncogene GTPase) • TP53 (Tumor protein P53) • TMB (Tumor Mutational Burden) • PD-1 (Programmed cell death 1)
|
TP53 mutation • KRAS mutation
|
Erbitux (cetuximab) • 5-fluorouracil